Dr. Zitha Mokomane is a Senior Research Specialist in the Population Health, Health Systems and Innovation research programme at the Human Sciences Research Council in South Africa. She holds a MA and a PhD (Family Demography), both from the Australian National University. Before joining the Human Science Research Council, Dr Mokomane was a Senior Lecturer in the Department of Population Studie...

Some Chemical Aspects of the Cancer Problem: DR. Societies and Meetings: CARL VOEGTLIN ................................... 41 The Illinois State Academy of Science: PROFESSOR ROBERT F. PATON. The North Carolina Academy Obitubary: of Science: PROPESSOR H. L. BLOMQUIST .............58 Dr. Fred Baker: PROFESSOR WILLIAM E. RITTER. ofecience: Lee Barker Walton: PROFESSOR HERBERT OSBORN. Special Arti...

This publication has been reviewed by: Dr. Jeff Stringer, Un. of Kentucky; Dr. George Parker, Purdue University; Dr. Burnell Fischer, IDNR Division of Forestry; Dr. John Kershaw, Un. of New Brunswick; Mr. Ron Rathfon, Purdue University Trees and shrubs often grow too large for the available space in urban areas. In the past, costly mechanical trimming was the sole method available to arborists ...

xi

I ntroduction: In recent years a number of emerging new therapies have become available for the treatment of severe asthma among which bronchial ther-moplasty is the only nonpharmacologic intervention that has been approved by the United States Food and Drug Administration in 2010. 1 Although bronchial thermoplasty has great promise for the patient with severe asthma and is now within the thera...

We appreciate the opportunity to reply to Dr. Kotze's and Dr. Yamamoto's letter1 about our paper “Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study”, recently accepted for publication in JCC.2 We agree with the first comment concerning the hypothesis that the use of anti-TNF (tumor necrosis factor)-α before surgery...

A number of autoimmune and other diseases have well established HLA associations; in many cases there is strong evidence for the direct involvement of the HLA class II peptide-presenting antigens, e.g., HLA DR-DQ for type 1 diabetes (T1D) and HLA-DR for rheumatoid arthritis (RA). The involvement of additional HLA region genes in the disease process is implicated in these diseases. We have devel...